Chondrosarcoma: With Updates on Molecular Genetics
2011
Chondrosarcoma: With Updates on Molecular Genetics
publication
Evidence: moderate
Author Information
Author(s): Kim Mi-Jung, Cho Kyung-Ja, Ayala Alberto G., Ro Jae Y.
Primary Institution: Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Weill Medical College of Cornell University, The Methodist Hospital, Houston, TX, USA
Conclusion
Chondrosarcoma is a complex malignant cartilage-forming tumor with varying subtypes and significant implications for diagnosis and treatment.
Supporting Evidence
- Chondrosarcoma is the third most frequent malignant bone tumor after multiple myeloma and osteosarcoma.
- Histologic grading is crucial for prognosis, with higher grades associated with worse outcomes.
- New genetic markers may provide insights into treatment and prognosis.
Takeaway
Chondrosarcoma is a type of cancer that forms in cartilage and can be hard to diagnose because it looks different in different people. New research is helping doctors understand it better.
Participant Demographics
Most patients are older than 50 years, with a male predilection of 1.5–2 to 1.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website